Lesson 4 Genesis Basis of Endometriosis

Applied Molecular Cellular Biology

🌸 What is Endometriosis?

  • Affects 5–10% of women of reproductive age.
  • Caused by tissue similar to the endometrium growing outside the uterus β†’ often on pelvic organs.
  • Symptoms: pelvic pain, infertility.
  • Diagnosis: usually requires surgery β†’ average 7-year delay.
  • Treatments: surgery or hormone therapy (often with side effects).
  • Classified by rASRM staging:
    • Stage I/II β†’ superficial lesions, minimal adhesions.
    • Stage III/IV β†’ severe disease with ovarian cysts (endometrioma), scarring, fibrosis, adhesions.

🧬 The Big GWAS Meta-Analysis

  • Combined 24 studies with 60,674 cases and 701,926 controls (Europe + East Asia).
  • Looked at 10.4 million SNPs.
  • Found 42 significant loci (31 new!) with 49 distinct genetic signals.
  • Explained ~5% of disease variance in severe (stage III/IV) cases.

πŸ‘‰ Stronger genetic effects in stage III/IV disease (especially ovarian endometriomas).


πŸ” Fine-Mapping & Functional Clues

  • Identified 6 high-confidence causal variants (all in noncoding regions).
  • Many SNPs regulate gene expression (eQTLs) or DNA methylation (mQTLs) in endometrium or blood.
  • Genes near hits are enriched in uterus, endometrium, and smooth muscle.

Key candidate genes:

  • GDAP1 β†’ neuronal development + dysmenorrhea severity.
  • SRP14/BMF β†’ links to hormone bioavailability + pain pathways.
  • NGF (nerve growth factor) β†’ affects nerve density around lesions.
  • SYNE1/ESR1 β†’ estrogen signaling + pain neurotransmitter regulation.
  • FSHB β†’ follicle-stimulating hormone signaling.

😣 Pain & Subphenotypes

  • Pain in endometriosis is complex:
    • Stage I/II disease correlated more strongly with pain than stage III/IV (!).
    • Specific SNPs (e.g., in SYNE1/ESR1) linked to dysmenorrhea, dyspareunia, chronic pelvic pain.
    • WT1 locus linked to early-onset menstrual pain (<18 yrs).
  • Suggests different genetic bases for pelvic pain vs severe ovarian lesions.

πŸ”— Comorbidity with Other Conditions

The study used genetic correlation (LD score regression) across traits:

  • Asthma (rg=0.17)
  • Osteoarthritis (rg=0.24)

🩸 Reproductive traits

  • Excessive/irregular menstruation (rg=0.69!)
  • Uterine fibroids (rg=0.40)
  • Earlier menarche, shorter cycles, earlier menopause, younger age at first birth.

πŸ€• Pain conditions

Strong overlap with 11 pain traits, including:

  • Migraine (rg=0.29)
  • Chronic back pain (rg=0.33)
  • Multisite chronic pain (MCP) (rg=0.43)
  • Dorsalgia (rg=0.45)

🧩 Multitrait Analysis (MTAG)

  • Combined GWAS of endometriosis + migraine + MCP.
  • Found 52 loci, including 18 new ones not seen in single-trait analysis.
  • Some loci shared across all 3:
    • MLLT10, BSN, NGF, SYNE1/ESR1, FSHB.
  • Many of these genes are tied to pain perception pathways.

🧠 Big Picture

  • Endometriosis genetics involve hormonal, immune, and neuronal pathways.
  • Pain isn’t just from lesions but from sensitization of the nervous system, partly genetic.
  • Explains why many patients also suffer from migraines, back pain, asthma, or arthritis.
  • Opens doors for new treatment targets β†’ maybe even drug repurposing.

πŸš€ Key Takeaways

  1. 42 loci, 49 signals = strongest genetic picture of endometriosis to date.
  2. Genetic risk is stronger in severe (stage III/IV) cases.
  3. Genes link to hormones, immune responses, and pain maintenance.
  4. Strong genetic overlap with other chronic pain and inflammatory diseases.
  5. Potential for personalized treatments targeting these shared pathways.

Quiz

Score: 0/29 (0%)